T
Tilman Bostel
Researcher at German Cancer Research Center
Publications - 75
Citations - 1363
Tilman Bostel is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 15, co-authored 66 publications receiving 1010 citations. Previous affiliations of Tilman Bostel include Heidelberg University & University of Mainz.
Papers
More filters
Journal ArticleDOI
Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia.
Andreas Burchert,Martin Müller,Philippe Kostrewa,Philipp Erben,Tilman Bostel,Simone Liebler,Rüdiger Hehlmann,Andreas Neubauer,Andreas Hochhaus +8 more
TL;DR: Treatment with IFN enables discontinuation of imatinib in most patients after priorImatinib/IFN combination therapy and may result in improved molecular response.
Journal ArticleDOI
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?
TL;DR: This study confirms that tumor location with regard to the SVZ is significantly associated with survival, and underline that survival in GBM patients is heterogeneous and influenced by multiple factors.
Journal ArticleDOI
Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Tanja Sprave,Vivek Verma,Robert Förster,Ingmar Schlampp,Thomas Bruckner,Tilman Bostel,Stefan Ezechiel Welte,Eric Tonndorf-Martini,Nils H. Nicolay,Jürgen Debus,Harald Rief +10 more
TL;DR: This randomized trial demonstrates the utility of palliative SBRT for spinal metastases, which was associated with a quicker and improved pain response.
Journal ArticleDOI
Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone
Sebastian Adeberg,Laila König,Tilman Bostel,Semi Harrabi,Thomas Welzel,Jürgen Debus,Stephanie E. Combs +6 more
TL;DR: GBM in close proximity to the SVZ was associated with decreased survival and had a higher risk of multifocal or distant progression, and opening of the ventricle during surgery had no effect on survival rates.
Journal ArticleDOI
Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer
Falk Roeder,Nils H. Nicolay,Nils H. Nicolay,Tam Nguyen,Ladan Saleh-Ebrahimi,Ladan Saleh-Ebrahimi,Vasilis Askoxylakis,Vasilis Askoxylakis,Tilman Bostel,Tilman Bostel,Felix Zwicker,Juergen Debus,Juergen Debus,Carmen Timke,Peter E. Huber,Peter E. Huber +15 more
TL;DR: IMRT with concurrent systemic therapy in the definitive treatment of esophageal cancer using an integrated boost concept with doses up to 60 Gy is feasible and yields good results with acceptable acute and late overall toxicity and low side effects to skin, lung and heart.